Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia. This evidence concerns the gene GP6 and autoimmune thrombocytopenic purpura.